Robert W. Coombs

28.4k total citations · 5 hit papers
235 papers, 16.8k citations indexed

About

Robert W. Coombs is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Robert W. Coombs has authored 235 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Infectious Diseases, 162 papers in Virology and 62 papers in Epidemiology. Recurrent topics in Robert W. Coombs's work include HIV Research and Treatment (161 papers), HIV/AIDS Research and Interventions (132 papers) and HIV/AIDS drug development and treatment (102 papers). Robert W. Coombs is often cited by papers focused on HIV Research and Treatment (161 papers), HIV/AIDS Research and Interventions (132 papers) and HIV/AIDS drug development and treatment (102 papers). Robert W. Coombs collaborates with scholars based in United States, Kenya and Peru. Robert W. Coombs's co-authors include Lawrence Corey, Ann C. Collier, Rhoda Sperling, Eleanor Jiménez, Mary Jo O’Sullivan, Edward M. Connor, Richard D. Gelber, James Balsley, Mary Culnane and Gwendolyn B. Scott and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert W. Coombs

230 papers receiving 16.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment

1994 2.5k citations Edward M. Connor, Rhoda Sperling et al. profile →
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment

1995 1.4k citations Edward M. Connor, Rhoda Sperling et al. Obstetrical & Gynecological Survey profile →
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine

1996 600 citations Ann C. Collier, Robert W. Coombs et al. profile →
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

1996 587 citations Rhoda Sperling, David E. Shapiro et al. profile →
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

2021 230 citations William A. Fischer, Joseph J. Eron et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Robert W. Coombs

Since Specialization

Citations

This map shows the geographic impact of Robert W. Coombs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Coombs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Coombs more than expected).

Fields of papers citing papers by Robert W. Coombs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Coombs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Coombs. The network helps show where Robert W. Coombs may publish in the future.

Co-authorship network of co-authors of Robert W. Coombs

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Coombs. A scholar is included among the top collaborators of Robert W. Coombs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Coombs. Robert W. Coombs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Validation of a Genotypic Assay to Quantify CXCR4- and CCR5-Tropic Human Immunodeficiency Virus Type-1 (HIV-1) Populations and a Comparison to Trofile® 2024 ·Viruses ·Daisy Ko, Sherry McLaughlin, Wenjie Deng, James I. Mullins, Joan Dragavon, (unknown), Robert W. Coombs, Lisa M. Frenkel	0
2	Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV 2024 ·The Journal of Infectious Diseases ·Nicole H. Tobin, Sarah L Brooker, Fan Li, Robert W. Coombs, Susan E. Cohn, Laura Moran, (unknown), (unknown), Emília M. Jalil, Unoda Chakalisa, Kimberly K. Scarsi, Carmen Zorrilla, Catherine Godfrey, Grace M. Aldrovandi	2
3	A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus breakdown → 2021 ·Science Translational Medicine ·William A. Fischer, Joseph J. Eron, Wayne Holman, Myron S. Cohen, Lei Fang, Laura J. Szewczyk, Timothy P. Sheahan, Ralph S. Baric, Katie R. Mollan, Cameron R. Wolfe, Elizabeth R. Duke, Masoud Azizad, Katyna Borroto–Esoda, David A. Wohl, Robert W. Coombs, Amy James Loftis, Paul Alabanza, (unknown), Wendy Painter	230
4	Reduction in infectious sars-cov-2 in treatment study of covid-19 with molnupiravir 2021 ·Wendy Painter, Timothy P. Sheahan, Ralph S. Baric, (unknown), (unknown), Lina Fang, Paul Alabanza, JJ Eron, Erin A. Goecker, Robert W. Coombs, Will Fischer	9
5	Development of a Novel Codon-Specific Polymerase Chain Reaction for the Detection of CXCR4-Utilizing HIV Type 1 Subtype B 2013 ·AIDS Research and Human Retroviruses ·Sherry McLaughlin, Luke C. Swenson, (unknown), Paul E. Hughes, P. Richard Harrigan, Robert W. Coombs, Lisa M. Frenkel	2
6	Transmitted HIV Resistance to First-Line Antiretroviral Therapy in Lima, Peru 2011 ·AIDS Research and Human Retroviruses ·Jaime Soria, Marta E. Bull, Caroline M. Mitchell, Alberto La Rosa, Sandra Dross, (unknown), Robert W. Coombs, Eduardo Ticona, Lisa M. Frenkel	16
7	Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150 2011 ·HIV Clinical Trials ·Beverly E. Sha, Camlin Tierney, Susan E. Cohn, Xin Sun, Robert W. Coombs, Lisa M. Frenkel, Spyros A. Kalams, Francesca Aweeka, Barbara Bastow, Arlene Bardeguez, (unknown), Alice Stek, (unknown)	31
8	A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen 2010 ·HIV Clinical Trials ·Scott M. Hammer, Heather J. Ribaudo, Roland Bassett, John W. Mellors, Lisa M. Demeter, Robert W. Coombs, Judith S. Currier, Gene D. Morse, John G. Gerber, Ana I. Martínez, William Spreen, Margaret A. Fischl, Kathleen Squires, (unknown)	16
9	HIV Type 1 Fails to Trigger Innate Immune Factor Synthesis in Differentiated Oral Epithelium 2009 ·AIDS Research and Human Retroviruses ·Wipawee Nittayananta, Florian Hladik, Mitchell Klausner, (unknown), Beverly A. Dale, Robert W. Coombs	7
10	Bacterial Vaginosis, Not HIV, Is Primarily Responsible for Increased Vaginal Concentrations of Proinflammatory Cytokines 2008 ·AIDS Research and Human Retroviruses ·Caroline M. Mitchell, Jennifer E. Balkus, Kathy Agnew, Susan E. Cohn, Amneris E. Luque, Richard L. Lawler, Robert W. Coombs, Jane Hitti	41
11	HIV Dynamics in Seminal Plasma during Primary HIV Infection 2008 ·AIDS Research and Human Retroviruses ·Joanne D. Stekler, (unknown), Sarah Holte, Janine Maenza, Claire E. Stevens, Joan Dragavon, Ann C. Collier, Robert W. Coombs	34
12	Herpes Simplex Virus (HSV) Suppression with Valacyclovir Reduces Rectal and Blood Plasma HIV‐1 Levels in HIV‐1/HSV‐2–Seropositive Men: A Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial 2007 ·The Journal of Infectious Diseases ·Richard A. Zuckerman, Aldo Lucchetti, William L. H. Whittington, Jorge L. Sánchez, Robert W. Coombs, Rosario Zuñiga, Amalia Magaret, Anna Wald, Lawrence Corey, Connie Celum	141
13	Short Communication: HIV Type 1 Zidovudine (ZDV) Resistance in Blood and Uterine Cervical Secretions of Pregnant Women 2006 ·AIDS Research and Human Retroviruses ·Lisa M. Frenkel, (unknown), (unknown), (unknown), Jane Hitti, D. Heather Watts, Ellen Cooper, Joan Dragavon, Robert W. Coombs	9
14	Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Arlene Bardeguez, David E. Shapiro, Lynne Mofenson, Robert W. Coombs, Lisa M. Frenkel, Mary Glenn Fowler, Sharon Huang, Rhoda Sperling, (unknown), Jorge Gandía, Robert Maupin, Carmen Zorrilla, Theodore B. Jones, Mary Jo O’Sullivan	27
15	A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding 2001 ·AIDS ·Lena Al‐Harthi, Andrea Kovács, Robert W. Coombs, Patricia Reichelderfer, David J. Wright, Mardge H. Cohen, Jonathan Cohn, Susan Cu‐Uvin, Heather Watts, (unknown), Suzanne K. Beckner, Alan Landay	50
16	Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract 2000 ·AIDS ·Patricia Reichelderfer, Robert W. Coombs, David J. Wright, Jonathan Cohn, David Burns, Susan Cu‐Uvin, Penny Baron, Mardge H. Cohen, Alan Landay, Suzanne K. Beckner, (unknown), Andrea Kovács	88
17	The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements 1999 ·AIDS ·Donald Brambilla, Patricia Reichelderfer, James W. Bremer, David E. Shapiro, Ronald C. Hershow, David Katzenstein, Scott M. Hammer, J. Brooks Jackson, Ann C. Collier, Rhoda Sperling, Mary Glenn Fowler, Robert W. Coombs	59
18	Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant 1997 ·Obstetrical & Gynecological Survey ·Rhoda Sperling, David E. Shapiro, Robert W. Coombs, John A. Todd, Steven A. Herman, George McSherry, Mary Jo O’Sullivan, Russell B. Van Dyke, Eleanor Jiménez, Christine Rouzioux, Patricia M. Flynn, John L. Sullivan	41
19	Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment breakdown → 1995 ·Obstetrical & Gynecological Survey ·Edward M. Connor, Rhoda Sperling, Richard D. Gelber, P.N. Kiselev, Gwendolyn B. Scott, Mary Jo O’Sullivan, (unknown), (unknown), William T. Shearer, (unknown), Eleanor Jiménez, Edward H. O'Neill, Brigitte Bazin, Jean‐François Delfraissy, Mary Culnane, Robert W. Coombs, Mary Elkins, Jack Moye, Pamela Stratton, James Balsley	1387
20	A Randomized, Double-Blind, Phase I/II Trial of Tumor Necrosis Factor and Interferon-Gamma for Treatment of AIDS-Related Complex (Protocol 025 from the AIDS Clinical Trials Group) 1992 ·AIDS Research and Human Retroviruses ·Jan M. Agosti, Robert W. Coombs, Ann C. Collier, (unknown), Jacqueline Benedetti, Howard S. Jaffe, Lawrence Corey	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact